Ponce-de-León, S., Torres, M., Soto-Ramírez, L. E., Calva, J. J., Santillán-Doherty, P., Carranza-Salazar, D. E., . . . Lozano-Dubernard, B. (2023). Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico. npj Vaccines, 8(1), . https://doi.org/10.1038/s41541-023-00662-6
Chicago-referens (17:e uppl.)Ponce-de-León, Samuel, et al. "Interim Safety and Immunogenicity Results from an NDV-based COVID-19 Vaccine Phase I Trial in Mexico." Npj Vaccines 8, no. 1 (2023). https://doi.org/10.1038/s41541-023-00662-6.
MLA-referens (9:e uppl.)Ponce-de-León, Samuel, et al. "Interim Safety and Immunogenicity Results from an NDV-based COVID-19 Vaccine Phase I Trial in Mexico." Npj Vaccines, vol. 8, no. 1, 2023, https://doi.org/10.1038/s41541-023-00662-6.
